–
TheTime is Israel’s best technology incubator. The Technological Incubators Program has also chosen the three best technology incubator graduate companies, to be presented at its annual convention.
–
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at office@jewishbusinessnews.com.
Thank you.
–
/By Ilan Shavit /
Sol Chip, Cartiheal, and ApiFix are the three best technology incubator graduates chosen by the Technological Incubators Program and which will be presented at its annual convention. TheTime is named Israel’s best incubator.
TheTime, established by Nir Tarlovsky and Ilan Shiloach. Managed by Uri Weinheber, TheTime has won the prize for the third consecutive time, thanks to the number and quality of the ventures it has adopted, their management, and the securing of follow-on investments for them, says the Technological Incubators Program.
–
–
Tendlines Group Mofet Venture Accelerator portfolio company Sol Chip Ltd. The company has raised several million dollars from Trendlines, Israel Electric Corporation’s (IEC) Karat Fund, and business development company DS2 Ltd.
–
–
CartiHeal’s first product, the Agili-C implant, is designed to regenerate cartilage and bone in bodily joints, by way of a minimally-invasive, single-step arthroscopic procedure. The implant’s unique structure, comprising a coral scaffold with biological modifications, causes the implant to biodegrade, and promotes the regeneration of true hyaline cartilage in its place.
Cartiheal’s shareholders include Elron Electronic Industries Ltd. (TASE:ELRN), Mori Arkin and Uri Geiger’s Accelmed, and Peregrine Ventures, the franchisee of Incentive at Ariel, where the company is based. Cartiheal has raised $10 million, and is conducting clinical trials. It expects to begin sales in Europe in a year.
–
–
Trendlines Misgav Venture Accelerator portfolio company Apifix Ltd. received European regulatory approval to market its ratcheting spinal correction implant. Designed for adolescent idiopathic scoliosis, the device consists of a ratchet that spans between two screws implanted into the spine. Some time after surgery, the patient stretches until the ratchet clicks a step, forcing in place the new minimum angle. Once soft tissue has adjusted, the patient proceeds to the next step, and so on gradually through the whole regimen.
Apifix Ltd. has raised a few hundred thousand dollars from the Maryland-Israel Development Fund and Trendlines. The company’s product also consists of two screws, which are implanted through a tiny incision through the skin, without the need for full surgery involving a large incision along the back.
